Skip to main content
. 2020 Apr;24(4):245–251. doi: 10.5005/jp-journals-10071-23385

Fig. 2.

Fig. 2

Receiver–operating characteristic curve for soluble urokinase-type plasminogen activator receptor and procalcitonin to differentiate sepsis from systemic inflammation response syndrome